Actively Recruiting
Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation
Led by AstraZeneca · Updated on 2025-12-23
400
Participants Needed
17
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multicentre observational study on treatment approaches and biomarkers in de novo metastatic hormone sensitive prostate cancer in Russian Federation
CONDITIONS
Official Title
Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients aged 18 years old
- Signed informed consent form including consent for tumor tissue testing
- Histologically confirmed high-aggressive metastatic prostate cancer with Gleason score 8-10
- Diagnosis of metastatic prostate cancer within 2 years prior to inclusion
- Availability of source medical documentation
- Presence of biopsy FFPE tumor tissue sample from routine clinical practice
- Unknown homologous recombination repair mutation status
You will not qualify if you...
- Participation in any interventional clinical trial since metastatic prostate cancer diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Research Site
Arkhangelsk, Russia
Actively Recruiting
2
Research Site
Barnaul, Russia
Actively Recruiting
3
Research Site
Chelyabinsk, Russia
Actively Recruiting
4
Research Site
Irkutsk, Russia
Not Yet Recruiting
5
Research Site
Krasnodar, Russia
Not Yet Recruiting
6
Research Site
Krasnoyarsk, Russia
Actively Recruiting
7
Research Site
Moscow, Russia
Not Yet Recruiting
8
Research Site
Moscow, Russia
Actively Recruiting
9
Research Site
Nizhny Novgorod, Russia
Not Yet Recruiting
10
Research Site
Obninsk, Russia
Actively Recruiting
11
Research Site
Omsk, Russia
Actively Recruiting
12
Research Site
Saint Petersburg, Russia
Not Yet Recruiting
13
Research Site
Saransk, Russia
Not Yet Recruiting
14
Research Site
Tomsk, Russia
Not Yet Recruiting
15
Research Site
Tyumen, Russia
Not Yet Recruiting
16
Research Site
Ufa, Russia
Not Yet Recruiting
17
Research Site
Yekaterinburg, Russia
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here